Moneycontrol PRO
HomeNewsBusinessMumbai airport to handle over half of SII's Covishield vaccine

Mumbai airport to handle over half of SII's Covishield vaccine

The Indian government will launch the vaccination drive from January 16, and the transportation of the vaccines may begun from January 11, to ensure a steady supply chain.

January 11, 2021 / 17:24 IST
The Mumbai airport already handles 600 tonnes of polio vaccines, produced by SII, a month.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The Mumbai airport will be handling over half of the Covishield vaccines coming out of Serum Institute of India's (SII's) Pune facility, helping them distribute within the country, and overseas.

    "The Mumbai airport will be catering to Serum Institute of India (SII). While the Pune airport will handle about 40-45 percent of the volumes, MIAL (Mumbai International Airport Ltd) will distribute the rest," MIAL's Chief Executive Officer Rajeev Jain told Moneycontrol.

    The Indian government will launch the vaccination drive from January 16, and the transportation of the vaccines may begun from January 11, to ensure a steady supply chain.

    Covishield is being jointly developed by Oxford University and British-Swedish company AstraZeneca, in collaboration with SII.

    Jain added that 25 tonnes of vaccines will come to the Mumbai airport everyday. "These vaccines have low shelf life and transportation has to be done as soon as possible. We have created a system such that it won't take more than 25 minutes for the vaccine shipment to cross the cargo terminal and board the aircraft," the senior executive added.

    COVID-19 Vaccine

    Frequently Asked Questions

    View more
    How does a vaccine work?

    A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

    How many types of vaccines are there?

    There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

    What does it take to develop a vaccine of this kind?

    Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

    View more
    Show

    MIAL already has a capability in handling sensitive pharmaceuticals shipments, with a capacity to handle 200 tonnes of vaccines a day. "We have the cold storage facilities needed to store these vaccines," Jain said.

    The airport already handles 600 tonnes of polio vaccines, produced by SII, a month. "That is nearly about 20 tonnes a day. We are equipped in vaccine logistics," said Jain.

    MIAL runs Chhatrapati Shivaji Maharaj International Airport, the second largest in the country.

    Apart from the Mumbai airport, the Rajiv Gandhi International Airport in Hyderabad will also have a critical role, as the southern metro is home to Bharat Biotech, which is making Covaxin. Also, Dr Reddy's Lab, which won the contract to test and manufacture Russia's Sputnik vaccine, is also based in Hyderabad.

    Covishield and Covaxin have got the nod from the government for emergency use.

    SII, which is the world's largest maker of vaccines, exports to more than 100 countries, but Pune's airport is not fully capable to handle the volumes. The Pune airport is controlled and owned by the Indian Air Force, and is undergoing runway resurfacing. It is closed from 8 pm to 8 am, limiting its ability to transport vaccines. 

    Read more: In vaccine transport, a pain point emerges - poor airport infra at pharma hubs

    MIAL has set up a dedicated team to oversee the COVID-19 vaccine transportation. The dedicated channel to transport the vaccines includes a facility that will control the temperature as the shipment is moved from the cold storage terminal to the aircraft.

    The airport will handle Covishield vaccines meant for use in India, and for exports too. The vaccine will cost about Rs 200 a vial.

    The government has conducted dry runs across the country.

    Prince Mathews Thomas
    Prince Mathews Thomas heads the corporate bureau of Moneycontrol. He has been covering the business world for 16 years, having worked in The Hindu Business Line, Forbes India, Dow Jones Newswires, The Economic Times, Business Standard and The Week. A Chevening scholar, Prince has also authored The Consolidators, a book on second generation entrepreneurs.
    first published: Jan 11, 2021 05:24 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseOutskill Genai